GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medios ILM1.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

11.40

+0.53%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medios

Its shares trade on XETRA under the ticker ILM1.DE. It has been listed since 1 January 1999. In the fiscal year to 31 December 2025, it reported revenue of €2.08bn and net income of €15.4m. At that date it held total assets of €903.0m and shareholders' equity of €514.2m.

Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin. The company wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The firm also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
1 Jan 1999
Employees
167
Website
medios.ag ↗

Leadership

Pay as last reported

  • Dr. Yann SamsonChairman of the Supervisory Board, since 2014€90,000
  • Mr. Matthias GaertnerChairman of the Management Board, Chief Executive Officer€538,414
  • Dr. Anke NestlerDeputy Chairwoman of the Supervisory Board, since 2021€70,000
  • Mr. Falk NeukirchChief Financial Officer, Member of the Management Board€472,581
  • Mr. Christoph PrusseitChief Innovation Officer, Member of the Management Board€465,381
  • Mr. Constantijn van RietschotenChief International Market, Member of the Management Board€232,200
  • Mr. Jens ApermannMember of the Supervisory Board
  • Dipl.-Kfm. Florian HergerMember of the Supervisory Board
  • Mr. Joachim MessnerMember of the Supervisory Board, since 2016€40,000
  • Ms. Claudia NickolausHead of Investor and Public Relations ESG Communications, since 2022

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medios AG is a reputable pharmaceutical company with several strengths that contribute to its success:

Weaknesses

  • Despite its strengths, Medios AG also faces certain weaknesses that can present challenges:

Opportunities

  • Medios AG can leverage various opportunities to expand and enhance its business:

Threats

  • Medios AG faces various threats that could impact its growth and profitability:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.